Covid-19 Impact on Drug Discovery Technologies Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Drug Discovery Technologies, including the following market information:
Major competitors identified in this market include Agilent Technologies, Inc, Abbott Laboratories, Inc., GE Healthcare Ltd., Albany Molecular Research Inc., Affymetrix Inc., Arqule Inc., Luminex Corporation, Bayer Healthcare AG, Novartis AG, Astrazeneca plc, etc.
Based on the Region:
- Global Drug Discovery Technologies Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Drug Discovery Technologies Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Drug Discovery Technologies Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Drug Discovery Technologies Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Major competitors identified in this market include Agilent Technologies, Inc, Abbott Laboratories, Inc., GE Healthcare Ltd., Albany Molecular Research Inc., Affymetrix Inc., Arqule Inc., Luminex Corporation, Bayer Healthcare AG, Novartis AG, Astrazeneca plc, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Biochips
- High throughput screening
- Pharmacogenomics
- Genomics
- Bioanalytical instruments
- Bioinformatics
- Nanotechnology
- Others
- Biopharmaceutical companies
- Pharmaceutical companies
- Research institutes
- Biotech companies
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Drug Discovery Technologies Industry
1.7 COVID-19 Impact: Drug Discovery Technologies Market Trends
2 GLOBAL DRUG DISCOVERY TECHNOLOGIES QUARTERLY MARKET SIZE ANALYSIS
2.1 Drug Discovery Technologies Business Impact Assessment - COVID-19
2.1.1 Global Drug Discovery Technologies Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Drug Discovery Technologies Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Drug Discovery Technologies Quarterly Market Size, 2019 VS 2020
3.2 By Players, Drug Discovery Technologies Headquarters and Area Served
3.3 Date of Key Players Enter into Drug Discovery Technologies Market
3.4 Key Players Drug Discovery Technologies Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON DRUG DISCOVERY TECHNOLOGIES SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Biochips
1.4.2 High throughput screening
1.4.3 Pharmacogenomics
1.4.4 Genomics
1.4.5 Bioanalytical instruments
1.4.6 Bioinformatics
1.4.7 Nanotechnology
1.4.8 Others
4.2 By Type, Global Drug Discovery Technologies Market Size, 2019-2021
5 IMPACT OF COVID-19 ON DRUG DISCOVERY TECHNOLOGIES SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Biopharmaceutical companies
5.5.2 Pharmaceutical companies
5.5.3 Research institutes
5.5.4 Biotech companies
5.2 By Application, Global Drug Discovery Technologies Market Size, 2019-2021
5.2.1 By Application, Global Drug Discovery Technologies Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Agilent Technologies, Inc
7.1.1 Agilent Technologies, Inc Business Overview
7.1.2 Agilent Technologies, Inc Drug Discovery Technologies Quarterly Revenue, 2020
7.1.3 Agilent Technologies, Inc Drug Discovery Technologies Product Introduction
7.1.4 Agilent Technologies, Inc Response to COVID-19 and Related Developments
7.2 Abbott Laboratories, Inc.
7.2.1 Abbott Laboratories, Inc. Business Overview
7.2.2 Abbott Laboratories, Inc. Drug Discovery Technologies Quarterly Revenue, 2020
7.2.3 Abbott Laboratories, Inc. Drug Discovery Technologies Product Introduction
7.2.4 Abbott Laboratories, Inc. Response to COVID-19 and Related Developments
7.3 GE Healthcare Ltd.
7.3.1 GE Healthcare Ltd. Business Overview
7.3.2 GE Healthcare Ltd. Drug Discovery Technologies Quarterly Revenue, 2020
7.3.3 GE Healthcare Ltd. Drug Discovery Technologies Product Introduction
7.3.4 GE Healthcare Ltd. Response to COVID-19 and Related Developments
7.4 Albany Molecular Research Inc.
7.4.1 Albany Molecular Research Inc. Business Overview
7.4.2 Albany Molecular Research Inc. Drug Discovery Technologies Quarterly Revenue, 2020
7.4.3 Albany Molecular Research Inc. Drug Discovery Technologies Product Introduction
7.4.4 Albany Molecular Research Inc. Response to COVID-19 and Related Developments
7.5 Affymetrix Inc.
7.5.1 Affymetrix Inc. Business Overview
7.5.2 Affymetrix Inc. Drug Discovery Technologies Quarterly Revenue, 2020
7.5.3 Affymetrix Inc. Drug Discovery Technologies Product Introduction
7.5.4 Affymetrix Inc. Response to COVID-19 and Related Developments
7.6 Arqule Inc.
7.6.1 Arqule Inc. Business Overview
7.6.2 Arqule Inc. Drug Discovery Technologies Quarterly Revenue, 2020
7.6.3 Arqule Inc. Drug Discovery Technologies Product Introduction
7.6.4 Arqule Inc. Response to COVID-19 and Related Developments
7.7 Luminex Corporation
7.7.1 Luminex Corporation Business Overview
7.7.2 Luminex Corporation Drug Discovery Technologies Quarterly Revenue, 2020
7.7.3 Luminex Corporation Drug Discovery Technologies Product Introduction
7.7.4 Luminex Corporation Response to COVID-19 and Related Developments
7.8 Bayer Healthcare AG
7.8.1 Bayer Healthcare AG Business Overview
7.8.2 Bayer Healthcare AG Drug Discovery Technologies Quarterly Revenue, 2020
7.8.3 Bayer Healthcare AG Drug Discovery Technologies Product Introduction
7.8.4 Bayer Healthcare AG Response to COVID-19 and Related Developments
7.9 Novartis AG
7.9.1 Novartis AG Business Overview
7.9.2 Novartis AG Drug Discovery Technologies Quarterly Revenue, 2020
7.9.3 Novartis AG Drug Discovery Technologies Product Introduction
7.9.4 Novartis AG Response to COVID-19 and Related Developments
7.10 Astrazeneca plc
7.10.1 Astrazeneca plc Business Overview
7.10.2 Astrazeneca plc Drug Discovery Technologies Quarterly Revenue, 2020
7.10.3 Astrazeneca plc Drug Discovery Technologies Product Introduction
7.10.4 Astrazeneca plc Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Drug Discovery Technologies Industry
1.7 COVID-19 Impact: Drug Discovery Technologies Market Trends
2 GLOBAL DRUG DISCOVERY TECHNOLOGIES QUARTERLY MARKET SIZE ANALYSIS
2.1 Drug Discovery Technologies Business Impact Assessment - COVID-19
2.1.1 Global Drug Discovery Technologies Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Drug Discovery Technologies Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Drug Discovery Technologies Quarterly Market Size, 2019 VS 2020
3.2 By Players, Drug Discovery Technologies Headquarters and Area Served
3.3 Date of Key Players Enter into Drug Discovery Technologies Market
3.4 Key Players Drug Discovery Technologies Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON DRUG DISCOVERY TECHNOLOGIES SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Biochips
1.4.2 High throughput screening
1.4.3 Pharmacogenomics
1.4.4 Genomics
1.4.5 Bioanalytical instruments
1.4.6 Bioinformatics
1.4.7 Nanotechnology
1.4.8 Others
4.2 By Type, Global Drug Discovery Technologies Market Size, 2019-2021
5 IMPACT OF COVID-19 ON DRUG DISCOVERY TECHNOLOGIES SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Biopharmaceutical companies
5.5.2 Pharmaceutical companies
5.5.3 Research institutes
5.5.4 Biotech companies
5.2 By Application, Global Drug Discovery Technologies Market Size, 2019-2021
5.2.1 By Application, Global Drug Discovery Technologies Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Agilent Technologies, Inc
7.1.1 Agilent Technologies, Inc Business Overview
7.1.2 Agilent Technologies, Inc Drug Discovery Technologies Quarterly Revenue, 2020
7.1.3 Agilent Technologies, Inc Drug Discovery Technologies Product Introduction
7.1.4 Agilent Technologies, Inc Response to COVID-19 and Related Developments
7.2 Abbott Laboratories, Inc.
7.2.1 Abbott Laboratories, Inc. Business Overview
7.2.2 Abbott Laboratories, Inc. Drug Discovery Technologies Quarterly Revenue, 2020
7.2.3 Abbott Laboratories, Inc. Drug Discovery Technologies Product Introduction
7.2.4 Abbott Laboratories, Inc. Response to COVID-19 and Related Developments
7.3 GE Healthcare Ltd.
7.3.1 GE Healthcare Ltd. Business Overview
7.3.2 GE Healthcare Ltd. Drug Discovery Technologies Quarterly Revenue, 2020
7.3.3 GE Healthcare Ltd. Drug Discovery Technologies Product Introduction
7.3.4 GE Healthcare Ltd. Response to COVID-19 and Related Developments
7.4 Albany Molecular Research Inc.
7.4.1 Albany Molecular Research Inc. Business Overview
7.4.2 Albany Molecular Research Inc. Drug Discovery Technologies Quarterly Revenue, 2020
7.4.3 Albany Molecular Research Inc. Drug Discovery Technologies Product Introduction
7.4.4 Albany Molecular Research Inc. Response to COVID-19 and Related Developments
7.5 Affymetrix Inc.
7.5.1 Affymetrix Inc. Business Overview
7.5.2 Affymetrix Inc. Drug Discovery Technologies Quarterly Revenue, 2020
7.5.3 Affymetrix Inc. Drug Discovery Technologies Product Introduction
7.5.4 Affymetrix Inc. Response to COVID-19 and Related Developments
7.6 Arqule Inc.
7.6.1 Arqule Inc. Business Overview
7.6.2 Arqule Inc. Drug Discovery Technologies Quarterly Revenue, 2020
7.6.3 Arqule Inc. Drug Discovery Technologies Product Introduction
7.6.4 Arqule Inc. Response to COVID-19 and Related Developments
7.7 Luminex Corporation
7.7.1 Luminex Corporation Business Overview
7.7.2 Luminex Corporation Drug Discovery Technologies Quarterly Revenue, 2020
7.7.3 Luminex Corporation Drug Discovery Technologies Product Introduction
7.7.4 Luminex Corporation Response to COVID-19 and Related Developments
7.8 Bayer Healthcare AG
7.8.1 Bayer Healthcare AG Business Overview
7.8.2 Bayer Healthcare AG Drug Discovery Technologies Quarterly Revenue, 2020
7.8.3 Bayer Healthcare AG Drug Discovery Technologies Product Introduction
7.8.4 Bayer Healthcare AG Response to COVID-19 and Related Developments
7.9 Novartis AG
7.9.1 Novartis AG Business Overview
7.9.2 Novartis AG Drug Discovery Technologies Quarterly Revenue, 2020
7.9.3 Novartis AG Drug Discovery Technologies Product Introduction
7.9.4 Novartis AG Response to COVID-19 and Related Developments
7.10 Astrazeneca plc
7.10.1 Astrazeneca plc Business Overview
7.10.2 Astrazeneca plc Drug Discovery Technologies Quarterly Revenue, 2020
7.10.3 Astrazeneca plc Drug Discovery Technologies Product Introduction
7.10.4 Astrazeneca plc Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Drug Discovery Technologies Assessment
Table 9. COVID-19 Impact: Drug Discovery Technologies Market Trends
Table 10. COVID-19 Impact Global Drug Discovery Technologies Market Size
Table 11. Global Drug Discovery Technologies Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Drug Discovery Technologies Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Drug Discovery Technologies Market Growth Drivers
Table 14. Global Drug Discovery Technologies Market Restraints
Table 15. Global Drug Discovery Technologies Market Opportunities
Table 16. Global Drug Discovery Technologies Market Challenges
Table 17. By Players, Drug Discovery Technologies Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Drug Discovery Technologies Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Drug Discovery Technologies Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Drug Discovery Technologies Market
Table 21. Key Players Drug Discovery Technologies Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Drug Discovery Technologies Market Size 2019-2021, (US$ Million)
Table 24. Global Drug Discovery Technologies Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Drug Discovery Technologies Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 57. Agilent Technologies, Inc Business Overview
Table 58. Agilent Technologies, Inc Drug Discovery Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Agilent Technologies, Inc Drug Discovery Technologies Product
Table 60. Agilent Technologies, Inc Response to COVID-19 and Related Developments
Table 61. Abbott Laboratories, Inc. Business Overview
Table 62. Abbott Laboratories, Inc. Drug Discovery Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Abbott Laboratories, Inc. Drug Discovery Technologies Product
Table 64. Abbott Laboratories, Inc. Response to COVID-19 and Related Developments
Table 65. GE Healthcare Ltd. Business Overview
Table 66. GE Healthcare Ltd. Drug Discovery Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. GE Healthcare Ltd. Drug Discovery Technologies Product
Table 68. GE Healthcare Ltd. Response to COVID-19 and Related Developments
Table 69. Albany Molecular Research Inc. Business Overview
Table 70. Albany Molecular Research Inc. Drug Discovery Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Albany Molecular Research Inc. Drug Discovery Technologies Product
Table 72. Albany Molecular Research Inc. Response to COVID-19 and Related Developments
Table 73. Affymetrix Inc. Business Overview
Table 74. Affymetrix Inc. Drug Discovery Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Affymetrix Inc. Drug Discovery Technologies Product
Table 76. Affymetrix Inc. Response to COVID-19 and Related Developments
Table 77. Arqule Inc. Business Overview
Table 78. Arqule Inc. Drug Discovery Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Arqule Inc. Drug Discovery Technologies Product
Table 80. Arqule Inc. Response to COVID-19 and Related Developments
Table 81. Luminex Corporation Business Overview
Table 82. Luminex Corporation Drug Discovery Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Luminex Corporation Drug Discovery Technologies Product
Table 84. Luminex Corporation Response to COVID-19 and Related Developments
Table 85. Bayer Healthcare AG Business Overview
Table 86. Bayer Healthcare AG Drug Discovery Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Bayer Healthcare AG Drug Discovery Technologies Product
Table 88. Bayer Healthcare AG Response to COVID-19 and Related Developments
Table 89. Novartis AG Business Overview
Table 90. Novartis AG Drug Discovery Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Novartis AG Drug Discovery Technologies Product
Table 92. Novartis AG Response to COVID-19 and Related Developments
Table 93. Astrazeneca plc Business Overview
Table 94. Astrazeneca plc Drug Discovery Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Astrazeneca plc Drug Discovery Technologies Product
Table 96. Astrazeneca plc Response to COVID-19 and Related Developments
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Drug Discovery Technologies Assessment
Table 9. COVID-19 Impact: Drug Discovery Technologies Market Trends
Table 10. COVID-19 Impact Global Drug Discovery Technologies Market Size
Table 11. Global Drug Discovery Technologies Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Drug Discovery Technologies Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Drug Discovery Technologies Market Growth Drivers
Table 14. Global Drug Discovery Technologies Market Restraints
Table 15. Global Drug Discovery Technologies Market Opportunities
Table 16. Global Drug Discovery Technologies Market Challenges
Table 17. By Players, Drug Discovery Technologies Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Drug Discovery Technologies Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Drug Discovery Technologies Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Drug Discovery Technologies Market
Table 21. Key Players Drug Discovery Technologies Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Drug Discovery Technologies Market Size 2019-2021, (US$ Million)
Table 24. Global Drug Discovery Technologies Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Drug Discovery Technologies Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Drug Discovery Technologies Market Size, 2019-2021 (US$ Million)
Table 57. Agilent Technologies, Inc Business Overview
Table 58. Agilent Technologies, Inc Drug Discovery Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Agilent Technologies, Inc Drug Discovery Technologies Product
Table 60. Agilent Technologies, Inc Response to COVID-19 and Related Developments
Table 61. Abbott Laboratories, Inc. Business Overview
Table 62. Abbott Laboratories, Inc. Drug Discovery Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Abbott Laboratories, Inc. Drug Discovery Technologies Product
Table 64. Abbott Laboratories, Inc. Response to COVID-19 and Related Developments
Table 65. GE Healthcare Ltd. Business Overview
Table 66. GE Healthcare Ltd. Drug Discovery Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. GE Healthcare Ltd. Drug Discovery Technologies Product
Table 68. GE Healthcare Ltd. Response to COVID-19 and Related Developments
Table 69. Albany Molecular Research Inc. Business Overview
Table 70. Albany Molecular Research Inc. Drug Discovery Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Albany Molecular Research Inc. Drug Discovery Technologies Product
Table 72. Albany Molecular Research Inc. Response to COVID-19 and Related Developments
Table 73. Affymetrix Inc. Business Overview
Table 74. Affymetrix Inc. Drug Discovery Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Affymetrix Inc. Drug Discovery Technologies Product
Table 76. Affymetrix Inc. Response to COVID-19 and Related Developments
Table 77. Arqule Inc. Business Overview
Table 78. Arqule Inc. Drug Discovery Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Arqule Inc. Drug Discovery Technologies Product
Table 80. Arqule Inc. Response to COVID-19 and Related Developments
Table 81. Luminex Corporation Business Overview
Table 82. Luminex Corporation Drug Discovery Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Luminex Corporation Drug Discovery Technologies Product
Table 84. Luminex Corporation Response to COVID-19 and Related Developments
Table 85. Bayer Healthcare AG Business Overview
Table 86. Bayer Healthcare AG Drug Discovery Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Bayer Healthcare AG Drug Discovery Technologies Product
Table 88. Bayer Healthcare AG Response to COVID-19 and Related Developments
Table 89. Novartis AG Business Overview
Table 90. Novartis AG Drug Discovery Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Novartis AG Drug Discovery Technologies Product
Table 92. Novartis AG Response to COVID-19 and Related Developments
Table 93. Astrazeneca plc Business Overview
Table 94. Astrazeneca plc Drug Discovery Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Astrazeneca plc Drug Discovery Technologies Product
Table 96. Astrazeneca plc Response to COVID-19 and Related Developments
LIST OF FIGURES
Figure 1. Drug Discovery Technologies Product Picture
Figure 2. Drug Discovery Technologies Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Drug Discovery Technologies Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Drug Discovery Technologies Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Drug Discovery Technologies Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Drug Discovery Technologies Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Drug Discovery Technologies Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Drug Discovery Technologies Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Drug Discovery Technologies Market Size Market Share, 2019-2021
Figure 1. Drug Discovery Technologies Product Picture
Figure 2. Drug Discovery Technologies Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Drug Discovery Technologies Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Drug Discovery Technologies Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Drug Discovery Technologies Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Drug Discovery Technologies Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Drug Discovery Technologies Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Drug Discovery Technologies Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Drug Discovery Technologies Market Size Market Share, 2019-2021
